Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Dec;344(6):639-44.
doi: 10.1007/BF00174747.

Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes

Affiliations

Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes

E Leung et al. Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec.

Abstract

While G protein-coupled receptors are often studied by analyzing antagonist radioligand: "cold" agonist inhibition curves using an independent site model, it is now clear that KL and KH values determined in these analyses are not reliable estimates of the affinities of the agonists for "free" and G protein-coupled forms of the receptor. Thus, such experiments cannot be used to contrast the characteristics of a given type of receptor in different tissues, i.e., to probe for the existence of receptor subtypes. Since treatment with N-ethylmaleimide treatment blocks receptor: Gi/Go protein interactions, such analyses on N-ethylmaleimide-pretreated membranes should allow direct assessment of the affinities of competing ligands for the free receptor or for multiple receptor subtypes. As A1 adenosine receptors couple to Gi, and perhaps to Go, we have performed A1 adenosine receptor radioligand "competition" studies first on control, then on N-ethylmaleimide-pretreated bovine cardiac and cerebral cortical membranes. Results of experiments with the antagonist radioligand [3H]xanthine amine congener appeared to be confounded by ligand binding to A2 adenosine receptors present in the cardiac membrane preparations. Further experiments utilized the A1-specific radioligand [3H]1,3-dipropyl-8-cyclopentylxanthine. These experiments confirmed once more that the KL values determined by computer analysis of "competition" curves performed on control membranes are not reliable estimates of the affinities of the competing ligand for free receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A–C. Inhibition curves for antagonist radioligand binding by R-RIA (circles) and NECA (triangles) to sites in cortical (open symbols) and cardiac (closed symbols) membranes. Panel A [3H]XAC, control membranes. Panel B [3H]XAC, NEM-pretreated membranes in presence of 0.1 mM Gpp(NH)p. Panel C [3H]CPX: NEM-pretreated membranes in presence of 0.1 mM Gpp(NH)p. Points shown are averages of duplicate determinations. Nonspecific binding as defined by theophylline (5 mM) is substracted from all data. The two site fits are shown as solid tines. One site fits are shown as – – – (heart) or ⋯ (Brain)

Similar articles

Cited by

References

    1. Abramson SN, McGonigle P, Molinoff PB. Evaluation of models for analysis of radioligand binding data. Mol Pharmacol. 1987;31:103–111. - PubMed
    1. Asano T, Ogasawara N. Uncoupling of γ-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: Effect of ethylmaleimide on purified GTP-binding proteins. Mol Pharmacol. 1986;29:244–249. - PubMed
    1. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. - PubMed
    1. Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hartman JD, Hays SJ, Huang CC. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-l,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg’s Pharmacol. 1987;335:59–63. - PubMed
    1. Drury AN, Szent-Györgi A. The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart. J Physiol (Lond) 1929;68:213–237. - PMC - PubMed

Publication types

Substances

LinkOut - more resources